PL1646391T3 - Zastosowanie pochodnych 2H-[1,3]-oksazyno[3,2-A]indolu do leczenia bólu neuropatycznego - Google Patents

Zastosowanie pochodnych 2H-[1,3]-oksazyno[3,2-A]indolu do leczenia bólu neuropatycznego

Info

Publication number
PL1646391T3
PL1646391T3 PL04740899T PL04740899T PL1646391T3 PL 1646391 T3 PL1646391 T3 PL 1646391T3 PL 04740899 T PL04740899 T PL 04740899T PL 04740899 T PL04740899 T PL 04740899T PL 1646391 T3 PL1646391 T3 PL 1646391T3
Authority
PL
Poland
Prior art keywords
oxazino
treatment
neuropathic pain
indole derivatives
indole
Prior art date
Application number
PL04740899T
Other languages
English (en)
Inventor
Angelo Guglielmotti
Lorenzo Polenzani
Alessandra Alisi
Nicola Cazzolla
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of PL1646391T3 publication Critical patent/PL1646391T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL04740899T 2003-07-18 2004-07-08 Zastosowanie pochodnych 2H-[1,3]-oksazyno[3,2-A]indolu do leczenia bólu neuropatycznego PL1646391T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001467A ITMI20031467A1 (it) 2003-07-18 2003-07-18 Farmaco attivo nel dolore neuropatico
PCT/EP2004/007633 WO2005014001A1 (en) 2003-07-18 2004-07-08 Use of 2h- [1, 3] - oxazino [3, 2-a] indole derivatives for the treatment of neuropathic pain
EP04740899A EP1646391B1 (en) 2003-07-18 2004-07-08 Use of 2h-[1,3]-oxazino[3,2-a]indole derivatives for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
PL1646391T3 true PL1646391T3 (pl) 2007-04-30

Family

ID=34131193

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04740899T PL1646391T3 (pl) 2003-07-18 2004-07-08 Zastosowanie pochodnych 2H-[1,3]-oksazyno[3,2-A]indolu do leczenia bólu neuropatycznego

Country Status (21)

Country Link
US (1) US20060211691A1 (pl)
EP (1) EP1646391B1 (pl)
JP (1) JP2006528142A (pl)
KR (1) KR20060033784A (pl)
CN (1) CN100409850C (pl)
AR (1) AR045993A1 (pl)
AT (1) ATE345137T1 (pl)
AU (1) AU2004262876B2 (pl)
CA (1) CA2526852C (pl)
DE (1) DE602004003252T2 (pl)
DK (1) DK1646391T3 (pl)
EA (1) EA008927B1 (pl)
ES (1) ES2276317T3 (pl)
GE (1) GEP20084307B (pl)
HK (1) HK1087027A1 (pl)
IL (1) IL172156A0 (pl)
IT (1) ITMI20031467A1 (pl)
PL (1) PL1646391T3 (pl)
PT (1) PT1646391E (pl)
UA (1) UA81050C2 (pl)
WO (1) WO2005014001A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2103305B1 (en) * 2006-12-26 2011-09-28 Taiho Pharmaceutical Co., Ltd. Therapeutic agent for diabetic neuropathy
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
GB9120628D0 (en) * 1991-09-27 1991-11-06 Fujisawa Pharmaceutical Co Pyrrolobenzoxazine derivatives and process for preparation thereof
RU2104279C1 (ru) * 1992-03-12 1998-02-10 Смитклайн Бичам Плс Конденсированное индольное производное или его фармацевтически приемлемая соль, фармацевтическая композиция, проявляющая активность антагониста 5-нт*004-рецептора
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
BR0012934A (pt) * 1999-08-04 2003-07-29 Icagen Inc Processos para a redução de dor e de ansiedade
US20040038874A1 (en) * 2002-08-22 2004-02-26 Osemwota Omoigui Method of treatment of persistent pain

Also Published As

Publication number Publication date
HK1087027A1 (en) 2006-10-06
WO2005014001A1 (en) 2005-02-17
KR20060033784A (ko) 2006-04-19
WO2005014001A9 (en) 2005-05-26
EA008927B1 (ru) 2007-08-31
CA2526852C (en) 2011-08-30
ES2276317T3 (es) 2007-06-16
JP2006528142A (ja) 2006-12-14
CA2526852A1 (en) 2005-02-17
DE602004003252T2 (de) 2007-05-03
CN1809361A (zh) 2006-07-26
US20060211691A1 (en) 2006-09-21
ATE345137T1 (de) 2006-12-15
EA200600270A1 (ru) 2006-06-30
DE602004003252D1 (de) 2006-12-28
EP1646391B1 (en) 2006-11-15
DK1646391T3 (da) 2007-03-19
PT1646391E (pt) 2007-01-31
AU2004262876A1 (en) 2005-02-17
ITMI20031467A1 (it) 2005-01-19
CN100409850C (zh) 2008-08-13
AU2004262876B2 (en) 2010-05-20
EP1646391A1 (en) 2006-04-19
AR045993A1 (es) 2005-11-23
IL172156A0 (en) 2006-04-10
UA81050C2 (en) 2007-11-26
GEP20084307B (en) 2008-02-11

Similar Documents

Publication Publication Date Title
IL169091A0 (en) Benzazepine derivatives for the treatment of neurological disorders
ZA200510255B (en) Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
HK1078858A1 (en) Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
SI1656346T1 (sl) 1,2,3,4-tetrasubstituiran indol za zdravljenje respiratornih bolezni
IL209352A0 (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
AU2003259249A1 (en) Pyridazinylpiperazine derivatives for treating pain
AP9901514A0 (en) Pyrazolopyrimidinone cgmp PDE5 inhibitors for the treatment of sexual disfunction
ZA200500618B (en) Combinations of drugs for the treatment of neoplasms
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
SI1685125T1 (sl) Derivati pirola, primerni za zdravljenje proliferativnih bolezni
GB0213869D0 (en) The treatment of pain
AU2003219981A1 (en) Benzimidazole-derivatives for the treatment of sexual dysfunction
PL375709A1 (pl) Pochodne [6,7-dihydro-5H-imidazo [1,2-alfa]-imidazolo-3-sulfonyloamino] propionamidu
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
IL172156A0 (en) Use of 2h- [1,3] - oxazinono [3,2 - a] indole derivatives for the treatment of neuropathic pain
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
HK1059782A1 (en) Indole derivatives useful for the treatment of cnsdisorders
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
GB0201025D0 (en) The treatment of degenerative diseases
IL164951A0 (en) The treatment of pain with lfendropil